MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Orthofix Medical Net Debt 2011-2026 | OFIX
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt Orthofix Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.5 M | 77.8 M | 63.5 M | -29.8 M | -66.1 M | - | -46.9 M | -69.6 M | -81.2 M | -39.6 M | -63.7 M | -36.8 M | -10.5 M | -11 M | 177 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 177 M | -81.2 M | -4.18 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
6.1 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
38.7 M | - | - | $ 1.77 B | USA |
 |
AdaptHealth Corp.
AHCO
|
1.64 B | $ 13.26 | 1.34 % | $ 1.79 B | USA |
 |
Allied Healthcare Products
AHPI
|
-3.31 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
252 K | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-16.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-230 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-32.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
6.46 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cardiovascular Systems
CSII
|
-64.6 M | - | 0.15 % | $ 844 M | USA |
 |
Electromed
ELMD
|
-10.5 M | $ 25.88 | -0.46 % | $ 219 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-22.8 M | $ 3.22 | -0.1 % | $ 121 M |  France |
 |
Conformis
CFMS
|
-26.2 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.8 M | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
11 M | $ 0.64 | 4.58 % | $ 39.8 M | USA |
 |
Globus Medical
GMED
|
-511 M | $ 91.47 | -2.38 % | $ 12.4 B | USA |
 |
Apollo Endosurgery
APEN
|
-22.5 M | - | - | $ 475 M | USA |
 |
ClearPoint Neuro
CLPT
|
3.85 M | $ 10.96 | -2.23 % | $ 310 M | USA |
 |
Helius Medical Technologies
HSDT
|
-5.12 M | $ 2.1 | -0.94 % | $ 1.28 M | USA |
 |
Eargo
EAR
|
-97.8 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
230 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
2.62 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-4.38 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-31.6 M | - | -1.42 % | $ 435 M | USA |
 |
LENSAR
LNSR
|
-10.2 M | $ 5.4 | 3.65 % | $ 64.6 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.02 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-2.3 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
LivaNova PLC
LIVN
|
-282 M | $ 60.79 | -4.13 % | $ 3.32 B |  Britain |
 |
Misonix, Inc.
MSON
|
5.72 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-4.95 M | - | - | $ 111 M |  Canada |
 |
Pulmonx Corporation
LUNG
|
-31.6 M | $ 1.22 | -4.69 % | $ 49.6 M | USA |
 |
Butterfly Network
BFLY
|
-65.9 M | $ 5.23 | -4.65 % | $ 1.11 B | USA |
 |
Intersect ENT, Inc.
XENT
|
50.8 M | - | - | $ 955 M | USA |
 |
PAVmed
PAVM
|
710 K | $ 8.7 | 3.57 % | $ 5.83 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
83.3 M | $ 15.29 | -3.35 % | $ 359 M | USA |
 |
Delcath Systems
DCTH
|
-42.5 M | $ 10.73 | -1.01 % | $ 384 M | USA |
 |
IRIDEX Corporation
IRIX
|
-5.23 M | $ 1.03 | -4.17 % | $ 17.4 M | USA |
 |
CONMED Corporation
CNMD
|
802 M | $ 36.72 | -3.04 % | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
-433 M | $ 54.89 | -0.33 % | $ 1.61 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.18 B | $ 83.99 | -1.59 % | $ 2.92 B | USA |
 |
Invacare Corporation
IVC
|
299 M | - | - | $ 24.7 M | USA |
 |
Sintx Technologies
SINT
|
-898 K | $ 2.35 | - | $ 6.52 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
-2.32 B | $ 81.59 | -2.24 % | $ 47.7 B | USA |
 |
Stryker Corporation
SYK
|
11 B | $ 322.09 | -2.1 % | $ 123 B | USA |
 |
MiMedx Group
MDXG
|
-148 M | $ 3.37 | 0.9 % | $ 498 M | USA |
 |
Tactile Systems Technology
TCMD
|
-75.4 M | $ 23.26 | -4.04 % | $ 532 M | USA |
 |
TELA Bio
TELA
|
5.33 M | $ 0.79 | -0.6 % | $ 37.1 M | USA |